Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis
Ended Project Grant Awarded Last action
- Award ID
- R44DK126600
- Recipient
-
Senseion Therapeutics Inc. UEI V2KQH21BGKY5
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,473,322
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$6,263 | |
| Amendment | $0 | |
| Amendment | $1,089,280 | |
| Amendment | $1,089,280 | |
| Amendment | -$25,632 | |
| Amendment | $25,632 | |
| Amendment | $25,632 | |
| Amendment | -$25,632 | |
| Amendment | $25,632 | |
| Amendment | -$25,632 | |
| Amendment | $0 | |
| Original award | $301,025 |
Show all 12
Quick answers
Who received award R44DK126600?
R44DK126600 was awarded to Senseion Therapeutics Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 16, 2020.
How much is award R44DK126600 worth?
$2,473,322 has been obligated on R44DK126600.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award